LIVZON PHARMA (01513) has accumulated repurchased 9.426 million shares of A shares.
Lizhu Pharmaceutical (01513) announced that as of February 28, 2025, the company has completed the centralized auction trading...
LIVZON PHARMA (01513) announced that as of February 28, 2025, the company repurchased a total of 9.426 million A shares through centralized bidding trading, accounting for 1.03% of the total share capital. The highest purchase price was RMB 38.37 per share, the lowest price was RMB 35.18 per share, and the total amount of funds used was RMB 342 million (excluding transaction costs). The repurchase mentioned above complies with the company's established share repurchase program.
Related Articles

US Stock Market Move | CECEP Solar Energy sector soared in early trading, with Jinko Solar (JKS.US) up more than 10%.

US Stock Market Move | Spot silver enters a historic era of "three-digit" prices, and concept stocks rise across the board.

AI leading stock SeaHub Technology, aims at providing AI intelligence body with images as its core business in China, has become the market leader in this industry with a market share of approximately 50%.
US Stock Market Move | CECEP Solar Energy sector soared in early trading, with Jinko Solar (JKS.US) up more than 10%.

US Stock Market Move | Spot silver enters a historic era of "three-digit" prices, and concept stocks rise across the board.

AI leading stock SeaHub Technology, aims at providing AI intelligence body with images as its core business in China, has become the market leader in this industry with a market share of approximately 50%.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


